Early continuous renal replacement therapy in cardiogenic shock patients with severe acute kidney injury undergoing extracorporeal membrane oxygenation

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.

Original languageEnglish
Pages (from-to)130-139
Number of pages10
JournalCardioRenal Medicine
Volume4
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Extracorporeal Membrane Oxygenation
Renal Replacement Therapy
Cardiogenic Shock
Acute Kidney Injury
Survival

Keywords

  • Acute kidney injury
  • Continuous renal replacement therapy
  • Extracorporeal membrane oxygenation
  • Glomerular filtration rate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Urology

Cite this

@article{79b47387f27e4daf86dccd045be50764,
title = "Early continuous renal replacement therapy in cardiogenic shock patients with severe acute kidney injury undergoing extracorporeal membrane oxygenation",
abstract = "Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.",
keywords = "Acute kidney injury, Continuous renal replacement therapy, Extracorporeal membrane oxygenation, Glomerular filtration rate",
author = "Lin, {Yen Chung} and Lin, {Yi Chun} and Lin, {Feng Yen} and Shih, {Chun Ming} and Wu, {Mai Szu} and Tzen-Wen Chen and Chen, {Hsi Hsien} and Chang, {Nen Chun} and Tsao, {Nai Wen} and Huang, {Chun Yao}",
year = "2014",
doi = "10.1159/000364835",
language = "English",
volume = "4",
pages = "130--139",
journal = "CardioRenal Medicine",
issn = "1664-3828",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Early continuous renal replacement therapy in cardiogenic shock patients with severe acute kidney injury undergoing extracorporeal membrane oxygenation

AU - Lin, Yen Chung

AU - Lin, Yi Chun

AU - Lin, Feng Yen

AU - Shih, Chun Ming

AU - Wu, Mai Szu

AU - Chen, Tzen-Wen

AU - Chen, Hsi Hsien

AU - Chang, Nen Chun

AU - Tsao, Nai Wen

AU - Huang, Chun Yao

PY - 2014

Y1 - 2014

N2 - Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.

AB - Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.

KW - Acute kidney injury

KW - Continuous renal replacement therapy

KW - Extracorporeal membrane oxygenation

KW - Glomerular filtration rate

UR - http://www.scopus.com/inward/record.url?scp=84907333936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907333936&partnerID=8YFLogxK

U2 - 10.1159/000364835

DO - 10.1159/000364835

M3 - Article

VL - 4

SP - 130

EP - 139

JO - CardioRenal Medicine

JF - CardioRenal Medicine

SN - 1664-3828

IS - 2

ER -